𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency—Preliminary evaluation

✍ Scribed by D. Craig Brater; David R. Rudy; James R. Voelker; Paula K. Greene; Todd Gehr; Dominic A. Sica

Publisher
Springer US
Year
1993
Tongue
English
Weight
433 KB
Volume
7
Category
Article
ISSN
0920-3206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral pharmacokinetics of pirenzepine in
Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis
✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1

Cyclophosphamide pharmacokinetics and do
Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency
✍ Haubitz, Marion; Bohnenstengel, Frank; Brunkhorst, Reinhard; Schwab, Matthias; H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 219 KB

## Background: Intravenous pulse administration of cyclophosphamide (cyc) has been successfully used for the treatment of various autoimmune diseases. these patients often present with impaired renal function or even end-stage renal failure. nevertheless, data concerning pharmacokinetics of cyc in